AXT (AXTI) has had the highest return since January 1, 2026 by a mid-cap US stock, returning 614.5%.
| ASSET | % RETURN |
|---|---|
AXT (AXTI) | 614.53% |
MaxLinear (MXL) | 415.59% |
Lightwave Logic (LWLG) | 390.15% |
Aehr Test Systems (AEHR) | 360.13% |
Immunitybio (IBRX) | 301.98% |
Ichor (ICHR) | 281.87% |
Ultra Clean (UCTT) | 217.48% |
Veradermics (MANE) | 205.59% |
Babcock & Wilcox Enterprises (BW) | 203.85% |
Erasca (ERAS) | 179.78% |
Silicon Motion Technology (SIMO) | 175.23% |
Enliven Therapeutics (ELVN) | 172.9% |
Tango Therapeutics (TNGX) | 165.54% |
Navitas Semiconductor (NVTS) | 156.67% |
Almonty Industries Inc Common Shares (ALM) | 151.94% |
Alumis (ALMS) | 140.63% |
Iridium Communications (IRDM) | 139.23% |
Day One Biopharmaceuticals (DAWN) | 131.75% |
Himax Technologies (HIMX) | 131.08% |
Spyre Therapeutics (SYRE) | 129.06% |
Vishay Intertechnology (VSH) | 128.07% |
Amprius Technologies (AMPX) | 122.84% |
Penguin Solutions (PENG) | 121.98% |
nLIGHT (LASR) | 117.74% |
Argan (AGX) | 115.23% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.